Nemaura Medical Inc (NMRD)

[BigBill1]

Here we go again, more delays! From todays 10Q:

Note 3: "As the Company now expects commercialization of the sugarBEAT device to occur in the first quarter ending June 30, 2020"

They are going by Nemaura's fiscal year, not calendar year.

So Dallas Burston won't be ready to launch until at least April, 2020. Due to the NASDAQ Rule 5550(a)(2) requiring listed securities to maintain a minimum closing bid price of $1.00 per share by January 11, 2020 and the continued delay by Dallas Burston I can easily see the SP going down into the .30's or worse over the next 4 months.